About Conference

We invite the participants from all over the world for the “14th World Congress on Personalized Medicine and Novel Therapy” which is going to be held on December 07-08, 2022 at Singapore City, Singapore. Conference Series is a world’s foremost event Organizer conducting International conferences in USA, Europe, Asia-Pacific and Middle East.

Personalized Medicine 2022 highlights the theme “Exploring Innovations and Knowledge of Personalized Medicine”. This will broadly cover the fields of Personalized Medicine as well as for initiation of new prospects and to explore new tendencies in the field of Personalized Medicine.

Why to attend?

The Personalized medicine 2022 will enlighten the world with recent advances in Personalized medicine and Novel research and inculcate new ideas about Novel health. Moreover, this Personalized medicine Conferences provides the participants a great networking with peers. Internationally prominent speakers, the novel techniques, and the modern updates in the Personalized medicine. Fields are the unique attributes of this conference. Personalized medicine symposiums and Workshops provide a dedicated forum for the advancement, execution and exchange of information about Personalized medicine and Novel Therapies.

Our aim is to aggregate community and to create a platform for exchange of information on technological developments, new scientific innovations and the effectiveness of various regulatory programs towards Personalized medicine 2022. It provides a premier technical forum for expressing and knowledge about the advanced research and developments, as well as exploration of new applications, technologies and to explore new trends in the field of Personalized medicine

Scientific Sessions

Track 01: Personalized medicine

Personalized medicine, precision medicine, or  theranostics is a medical model that separates people into different groups with medical decisions, practices, interventions and/or products being tailored to the individual patient based on their predicted response or risk of disease. The terms personalized medicine, precision medicine, stratified medicine and P4 medicine are used interchangeably to describe this concept  though some authors and organisations use these expressions separately to indicate particular nuances. Personalized medicine is an emerging practice of medicine that uses an individual's genetic profile to guide decisions made in regard to the prevention, diagnosis, and treatment of diseases.

Track 02: Personalized medicine to heart

Personalized medicine is an emerging concept involving managing the health of patients based on their individual characteristics, including particular genotypes. Cardiovascular diseases are heritable traits, and family history information is useful for risk prediction. As such, determining genetic information  may also be applied to risk prediction. Furthermore, accumulating evidence suggests that genetic background can provide guidance for selecting effective treatments and preventive strategies in individuals with particular genotypes. Research on cardiovascular genetics has had some spectacular successes in uncovering new therapeutic targets—for example, the finding that people with inactivating mutations in the gene encoding the trafficking protein PCSK9 are at a much lower risk for heart attacks led to the development of antibody therapy targeting this protein.

Trcak 03: Personalized Immunotherapy

Personalized therapies are emerging as a promising approach to treat cancer. Because of the diversity of genetic background and medical history, customizing treatments and leveraging specific characteristics of individual patients are the key strategies to ensure the best possible outcome. Cancer immunotherapies are at the forefront of this type of Personalized approach. In recent years, we have observed the unprecedented success of immunotherapies that harness the patient’s own immune system to fight cancer. There are currently three major approaches to T cell-based cancer immunotherapy, namely, active vaccination, adoptive cell transfer therapy and immune checkpoint blockade. Recently, this latter approach has demonstrated remarkable clinical benefits, putting cancer immunotherapy under the spotlight.

Track 04: Personalized medicine: Drug discovery and patient care.

Personalized medicine, the use of marker-assisted diagnosis and targeted therapies derived from an individual's molecular profile, will impact the way drugs are developed and medicine is practiced. Knowledge of the molecular basis of disease will lead to novel target identification, toxicogenomic markers to screen compounds and improved selection of clinical trial patients, which will fundamentally change the pharmaceutical industry. The traditional linear process of drug discovery and development will be replaced by an integrated and heuristic approach Advances in human genome research are opening the door to a new paradigm for practising medicine that promises to transform healthcare. Personalized medicine, the use of marker-assisted diagnosis and targeted therapies derived from an individual's molecular profile, will impact the way drugs are developed and medicine is practiced.

Track 05: Individualized Treatment through Personalized Medicine

Individualized Treatment through Personalized Medicine is a approach that can be undertaken to develop and apply clinical decision support in electronic health record systems to achieve personalized medical care. In addition, to represent meaningful benefits to personalized decision-making, a comparison of current and future applications of clinical decision support to enable individualized medical treatment plans is presented.  It recognizes that complex diseases should no longer be considered as a single entity. One disease may have many different forms, or subtypes resulting from the complex interaction of our biological make-up and the diverse pathological and physiological processes in our bodies. These will not only vary between patients who have the same disease but also within an individual patient as they get older and their body changes.

Track 06 : Personalized Medicine in Oncology

Precision Medicine in Oncology is doled out to illuminating, instructing, and encouraging the trading of clinically pertinent data with respect to the disclosure and utilization of new Drug regimens, Molecular biomarkers, Cancer genomics, Molecular growth and Diagnostics in strong tumors and hematologic malignancies, and in addition their effect on oncology watch over patients. Over late decades Cancer investigate has found an incredible and personalized medication to tumor research and treatment. The development of cost-effective technologies able to comprehensively assess DNA, RNA, protein, and metabolites in patient tumours has fuelled efforts to tailor medical care. Indeed validated molecular tests assessing tumour tissue or patient germ line DNA already drive therapeutic decision making.

Track 07: Pharmacogenomics & Personalized Medicine

In pharmacogenomics, genomic information is used to study individual responses to drugs. When a gene variant is associated with a particular drug response in a patient, there is the potential for making clinical decisions based on genetics by adjusting the dosage or choosing a different drug, for example. Scientists assess gene variants affecting an individual's drug response the same way they assess gene variants associated with diseases: by identifying genetic loci associated with known drug responses, and then testing individuals whose response is unknown. Modern approaches include multigene analysis or whole-genome Single Nucleotide Polymorphism (SNP) profiles, and these approaches are just coming into clinical use for drug discovery and development. The vision of personalized medicine, the practice of medicine where each patient receives the most appropriate medical treatments and the most fitting dosage and combination of drugs based on his or her genetic make-up.

Track 08: Metabolomics in Personalized medicine

Metabolomics, which is defined as the comprehensive analysis of metabolites in a biological specimen, is an emerging technology that holds promise to inform the practice of Personalized Medicine. Historically, small numbers of metabolites have been used to diagnose complex metabolic diseases as well as monogenic disorders such as inborn errors of metabolism. Current metabolomic technologies go well beyond the scope of standard clinical chemistry techniques and are capable of precise analyses of hundreds to thousands of metabolites. The ability of biomarkers to improve treatment and reduce healthcare costs is potentially greater than in any other area of current medical research.

Market Analysis

The Euro market estimation for customized drugs is anticipated to develop at the exacerbated yearly development rate of 7.5% amid 2009 to 2015. This development in future is required to be driven by various elements such as cost investment funds on medicines, early conclusion of ailment, medication wellbeing, quiet consistence, and improvement of treatments. Right now, America commands the business sector for customized pharmaceutical; be that as it may, progression in innovation and advancements in the field of DNA is required to set up Personalized Medicine Market in USA, UK, France, India, China, and Japan.

Quick advances in innovation have made it attainable to recognize a man's one of a kind genome. One individual varies from another by a large number of varieties in the genome, and a considerable lot of these varieties influence weakness to infection and reaction to medications. More noteworthy comprehension of individual genomes is permitting researchers and clinicians to start to "customize" medication. The Personalized Genomic Medicine insurgency will yield more viable medications with less unfavourable reactions and lead to longer, more beneficial lives and lower human services costs. The customized pharmaceutical industry in the United States as of now produces $286 billion every year in incomes and is developing by 11% every year, as indicated by Price water house Coopers Research at JAX Genomic Medicine will add to customized solution by uncovering how genomic varieties influence wellbeing, malady and medication reaction.

The worldwide Personalized Medicine Industry was esteemed at 8,956.14 billion EUR in 2014 and is relied upon to achieve 2179.32 billion EUR in 2022, developing at a CAGR of 11.8% over the gauge period. Key drivers of the business sector incorporate developing improvement of cutting edge sequencing, entire genome innovation, partner diagnostics and developing number of retail facilities

Targeted audience

• Psychiatrist
• Cardiologists
• Oncologists
• Physiotherapists
• Cancer therapy Institutes
• Endocrinologist
• Neurologist
• Nephrologist
• Scientists
• Directors/Managers
• Presidents & Vice Presidents/ Directors / Administrators
• Business Entrepreneurs
• COPD Associations/ Societies
• Young Researchers
• Medical Students
• Nurses
• Medical Devices Companies
• Palliative care Doctors/Nurses

Past Conference Reports

Personalised Medicine 2021

Conference series LLC Ltd, hosted the “14th World Congress on Personalized Medicine and Novel Therapy” to be held in  during December 03-04, 2021 at Singapore city, Singapore. Which based on the theme “Exploring Innovations and Knowledge of Personalized Medicine" It was a great success, where eminent speakers from various reputed institutions and organizations with their resplendent presence addressed the gathering. The adepts who promulgated the theme with their exquisite talks were: Lejla R. Stojanovic (Serbia), Alexandre De Luca (Argentina), Florian Forelli (France),  Maude Traulle (France). Scientific sessions discussed during Conference are about Personalized medicine for Diabetes, Personalized Medicine in Oncology, Treatment of Genetic Disorders, Precision Medicine and Novel Technology, Noval Therapy in Hospice, Aging and Geriatrics.

Personalized Medicine 2020

Conference series LLC Ltd, hosted the “Personalized Medicine and Novel Therapy” held on May 13, 2020 at Berlin, Germany. but due to the pandemic situation it is organized as webinar. We would like to thank all of our wonderful Keynotes, Speakers, and Students for making Personalized Medicine 2020 Webinar a successful online event. The adepts who promulgated the theme with their exquisite talks were: Vania Assaly (Brazil), Alexandre De Luca (Argentina), Winston Vo (USA), Rauph GuimAraes (Brazil). Scientific sessions discussed during Conference are about Personalized Palliative care, Drug Target Discovery and Integration, Personalized Biological Therapies, Treatment of Genetic Disorders, Personalized Medicine in Oncology.

Small Note

Also, we thank the Organizing Committee, Keynote Speakers, Chairs & Co-Chairs and also the Moderator of the conference whose support and efforts made the conference to move in the path of success. With the unique feedbacks from the conference, we are pleased to announce the “14^th World Congress on Personalized Medicine and Novel Therapy” to be held during December 07-08, 2022 in Singapore city, Singapore.